Skip to content

Seizure Detection and Warning System in Epilepsy Patients

A Pivotal, Phase II Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02555410
Enrollment
11
Registered
2015-09-21
Start date
2013-01-31
Completion date
2017-07-07
Last updated
2017-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Generalized Tonic-Clonic Seizures

Brief summary

This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.

Detailed description

The Brain Sentinel™ Seizure Detection and Warning System is intended for monitoring children and adults with a history or significant risk of generalized tonic-clonic seizures in the home or healthcare facilities, during the titration or withdrawal of anti-epileptic drugs, and for continuous monitoring (night time or any other time of day) of individuals due to their history or risk of generalized tonic-clonic seizures. The device will withstand activities of daily living including showers and sleep.

Interventions

A sEMG based automated seizure detection and warning system worn on the biceps

Sponsors

Brain Sentinel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Subject has a history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization. 2. Male or female between the ages of 2-99. 3. Has an upper arm circumference which is adequate for proper fit of the EMG monitor (at least 14cm). 4. Be able to tolerate wearing the device on the upper arm. 5. If female and of childbearing potential, has a negative pregnancy test. 6. Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments. 7. Subject and/or Primary Caregiver must be competent to follow all study procedures. 8. Is able to read, speak and understand English.

Exclusion criteria

1. Does not have a documented history of generalized seizures. 2. The subject's upper arm circumference not adequate for proper fit of the EMG monitor (less than 14cm) 3. Pregnant female 4. Subject/Caregiver is unable to provide consent. 5. Subject/Caregiver is not competent to follow home study procedures. 6. The subject is homeless or in a home without a power supply.

Design outcomes

Primary

MeasureTime frameDescription
Test the function of the system including ability to acquire EMG signal, analyze and successfully transmit the analysis to the base station, and identify and transmit all alert conditions.up to 1 monthThe overall usability and technical features will be assessed through questionnaires and surveys as the Seizure Detection and Warning System will be used within a home setting.

Secondary

MeasureTime frameDescription
Compare the accuracy of the EMG based system's log to the subject's seizure diaryup to one monthComparison of the subject's seizure diary to the EMG based seizure detection system's seizure logs will help determine overall function.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026